News
Big Data in Neuroimaging
Wearables, Big Data, virtual reality, 3D printing … are many emerging technologies that are being taken into the health sector by the hands of daring...
At RSNA 2022, our team discussed the latest advances in imaging trials software, including state-of-the-art digital biomarkers algorithms.
We had the pleasure to participate in one of the most important events in the radiology industry, the RSNA 2022 edition, at McCormick Place in Chicago from November 27th to December 1st.
Throughout this event, our team discussed the latest advances in imaging trials software, including state-of-the-art digital biomarkers algorithms.
During the session Asymmetry in FA Values as a Tool for Evaluating mTBI Patients, hosted by Murray Solomon MD (Los Gatos MRI) and Ioannis Pappas from the Laboratory of Neuro Imaging (Toga Lab), University of Southern California. We learned how our Q-FiberMapper (Q-FM) contributed to the success of the study.
The researchers, explained that they used our Q-FiberMapper workflow to calculate FA, MD, RD and AD values separately for homologous right and left tracts: IFOF, ILF, SLF, CST, UNC, Cingulum and Fornix ad for the Forceps Minor and Forceps Major.
Realizing that some of our platform capabilities are being used to empower major breakthroughs was priceless.
It was an amazing experience to get to learn more about the challenges that most of you face when running imaging clinical trials or performing your daily radiological tasks. We are glad to corroborate that our platform solutions covered most of them.
After four days of non-stop activities we had to say goodbye to this year’s edition of the Annual meeting of the Radiological Society of North America. Now it’s time to keep working on building new and disruptive solutions to surprise you at RSNA 2023!
Thanks to your valuable insights, we will continue to develop solutions to empower your breakthroughs.
